Buddy E. Cantrell

Synthesis and Evaluation of a Series of Novel 2-[(4-Chlorophenoxy)methyl]- benzimidazoles as Selective Neuropeptide Y Y1 Receptor Antagonists

Hamideh Zarrinmayeh, Anne M. Nunes, Paul L. Ornstein et al. · Journal of Medicinal Chemistry · 1998 · 153 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Discovery of a Potent, Peripherally Selective trans-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine Opioid Antagonist for the Treatment of Gastrointestinal Motility Disorders

Dennis M. Zimmerman, J. S. Gidda, Buddy E. Cantrell et al. · Journal of Medicinal Chemistry · 1994 · 118 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Identification of the First <i>trans</i>-(3<i>R</i>,4<i>R</i>)- Dimethyl-4-(3-hydroxyphenyl)piperidine Derivative To Possess Highly Potent and Selective Opioid κ Receptor Antagonist Activity

James B. Thomas, Robert N. Atkinson, Richard B. Rothman et al. · Journal of Medicinal Chemistry · 2001 · 106 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonists

Hamideh Zarrinmayeh, Dennis M. Zimmerman, Buddy E. Cantrell et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 91 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Biarylpropylsulfonamides as Novel, Potent Potentiators of 2-Amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)- propanoic Acid (AMPA) Receptors

Paul L. Ornstein, Dennis M. Zimmerman, M. Brian Arnold et al. · Journal of Medicinal Chemistry · 2000 · 76 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14